Description
Description & Mechanism
BPC-157 is a synthetic oligopeptide consisting of fifteen amino acids, corresponding to a defined sequence originally identified within a larger gastric-derived protein. In research contexts, it is studied as a discrete pentadecapeptide with reproducible physicochemical properties, allowing its use in biochemical, cellular, and preclinical experimental systems.
In biochemical and cellular research models, BPC-157 has been reported to interact with multiple signalling pathways, including nitric oxide–associated mechanisms, growth factor-related signalling, and cytoskeletal regulatory processes. Observed molecular and cellular responses are highly dependent on experimental conditions, concentration, exposure duration, and model system. As such, BPC-157 is utilised as a molecular probe for investigating peptide-mediated signalling behaviour rather than defined biological or physiological outcomes.
Applications in Research
- As a molecular tool to study short peptide–mediated signalling pathways
- Investigation of intracellular signalling networks involving nitric oxide–associated and growth factor-related pathways
- In vitro studies examining cytoskeletal organisation and cell–matrix interaction dynamics
- Preclinical or ex vivo experimental models for mechanistic investigation of oligopeptide signalling
Specifications Summary
| Parameter | Typical Value / Range |
|---|---|
| Purity (HPLC) | ≥ 99 |
| Appearance | White to off-white lyophilised powder |
| Molecular Weight | 1479.6 g/mol |
| Peptide Type | Synthetic pentadecapeptide |
| Solubility | Water, buffered aqueous solutions |
| Storage | –20 °C, desiccated, dark |
| Pack Size | 3,000 mg (bulk) |
Handling, Reconstitution & Stability
- Weigh under dry conditions; peptide is hygroscopic
- Reconstitute in sterile water or appropriate buffered aqueous solution depending on assay requirements
- Avoid vigorous agitation during dissolution
- Filter sterilize if required (e.g. 0.22 µm) prior to use
- Aliquot and store reconstituted solutions at –20 °C or below to minimise degradation
- Avoid repeated freeze–thaw cycles
Precautions & Notes
- Experimental behaviour of BPC-157 is dependent on concentration, model system, and exposure conditions
- Due to reported interaction with multiple signalling pathways, appropriate experimental controls are recommended
- Prolonged exposure to light, elevated temperature, or aqueous environments may reduce stability
- As of 2022, BPC-157 (PL-14736) is listed by the World Anti-Doping Agency (WADA) under the S0 category of prohibited substances; this designation is unrelated to research use
- Intended strictly for laboratory research use; not for human or veterinary application










